Structural biasing elements for in-cell histone deacetylase paralog selectivity

Journal of the American Chemical Society

Volumn 125, Issue 19, 2003, Pages 5586-5587

  Wong, Jason C ^a   Hong, Roger ^a   Schreiber, Stuart L ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIOXANE DERIVATIVE; ANILIDE; CELL ENZYME; HISTONE DEACETYLASE;

ARTICLE; CELL CYCLE; DEACETYLATION; GENETIC TRANSCRIPTION; MICROTUBULE; MOLECULAR CLONING; MOLECULAR DYNAMICS; STEREOCHEMISTRY;

ANILIDES; DIOXANES; ENZYME INHIBITORS; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0038274087     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja0341440     Document Type: Article

References (21)

1. Hassig, C. A.; Schreiber, S. L. Curr. Opin. Chem. Biol. 1997, 1, 300-308.
2. (a) Taunton, J.; Hassig, C. A.; Schreiber. S. L. Science 1996, 272, 408-411.
3. (b) Yang, W. M.; Yao, Y.; Sun, J.; Davie, J. R.; Seto. E. J. Biol. Chem. 1997, 272, 28001-28007.
4. (c) Grozinger, C.; Hassig, C.; Schreiber, S. L. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 4868-4873.
5. (d) Kao, H.; Downes, M.; Ordentlich, P.; Evans, R. M. Genes Dev. 2000, 275, 15254-15264.
6. (e) Zhou, X.; Marks, P. A.; Rifkind, R. A.; Richon, V. M. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 10572-10577.
7. (f) Kao, H. Y.; Lee, C. H.; Komarov, A.; Han, C. C.; Evans, R. M. J. Biol. Chem. 2001, 277, 187-193.
8. (g) Gao, L.; Cueto, M. A.; Asselbergs, F.; Atadja, P. J. Biol. Chem. 2002, 277, 25748-25755.
9. Kouzarides, T. EMBO J. 2000, 19, 1176-1179.
10. Piperno, G.; LeDizet, M.; Chang, X. J. Cell Biol. 1987, 104, 289-302.
11. Luo, J.; Fei, S.; Chen, D.; Shiloh, A.; Gu, W. Nature 2000, 408, 377-381.
12. Grozinger, C. M.; Schreiber, S. L. Chem. Biol. 2002, 9, 3-16.
13. Sternson, S. M.; Wong, J. C.; Grozinger, C. M.; Schreiber, S. L. Org. Lett. 2001, 3, 4239-4242.
14. Haggarty, S. J.; Koeller, K. M.; Wong, J. C.; Butcher, R. A.; S. L. S. Chem. Biol., in press.
15. Hubbert, C.; Guardiola, A.; Shao, R.; Kawaguchi, Y.; Ito, A.; Nixon, A.; Yoshida, M.; Wang, X.; Yao, T. Nature 2002, 417, 455-458.
16. Haggarty, S. J.; Koeller, K. M.; Wong, J. C.; Grozinger, C. M.; S. L. S. Proc. Natl. Acad. Sci. U.S.A., in press.
17. (a) Richon, V. M.; Emiliani, S.; Verdin, E.; Webb, Y.; Breslow, R.; Rifkind, R. A.; Marks, P. A. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 3003-3007.
18. (b) He, L. Z.; Tolentino, T.; Grayson, P.; Zhong, S.; Warrell, R. P., Jr.; Rifkind, R. A.; Marks, P. A.; Richon, V. M.; Pandolfi, P, P. J. Clin. Invest. 2001, 108, 1321-1330.
19. (c) Butler, L. M.; Agus, D. B.; Scher, H. I.; Higgins, B.; Rose, A.; Cordon-Cardo, C.; Thaler, H. T.; Rifkind, R. A.; Marks, P. A.; Richon, V. M. Cancer Res. 2002, 60, 5165-5170.
20. Remiszewski, S. W. Curr. Opin. Drug Discovery Dev. 2002, 5, 487-499.
21. See Supporting Information.